Lyme Disease Symptoms In Dogs: Comprehensive Veterinary Reference Guide

Lyme disease, also known as Lyme borreliosis, is a globally significant tick-borne bacterial infection caused by the spirochete Borrelia burgdorferi sensu lato complex. In dogs, the clinical presentation of Lyme disease can range from subclinical infection to severe, multi-systemic illness. Understanding the full spectrum of lyme disease symptoms in dogs is critical for veterinary professionals and pet owners alike, as early recognition and appropriate intervention can prevent chronic complications.

This comprehensive veterinary reference guide provides an exhaustive analysis of the clinical signs, diagnostic reasoning, regional epidemiological variations, and evidence-based management strategies for canine Lyme disease. We will cover signs of lyme disease in dogs, the pathophysiological basis of symptom development, and important differential diagnoses that must be considered.

Quick Q&A: Lyme Disease in Dogs

Question: What are the most common symptoms of Lyme disease in dogs? Answer: The most characteristic symptom is acute, shifting-leg lameness (limping that moves from one leg to another), often accompanied by fever, lethargy, and swollen, painful joints. Many infected dogs, however, show no clinical signs at all. If left untreated, Lyme disease can progress to affect the kidneys (Lyme nephritis), which is a serious and potentially fatal complication.

1. Introduction: Understanding Canine Lyme Disease

Lyme disease is a vector-borne zoonotic illness caused by spirochete bacteria of the Borrelia burgdorferi sensu lato group. The primary vectors are hard-bodied ticks of the Ixodes genus, including Ixodes scapularis (black-legged tick or deer tick) in eastern North America, Ixodes pacificus (western black-legged tick) in western North America, Ixodes ricinus (sheep tick or castor bean tick) in Europe, and Ixodes persulcatus (taiga tick) in Asia and parts of Eastern Europe.

The disease was first recognized in humans in Lyme, Connecticut, USA, in 1975, and was subsequently identified in dogs shortly thereafter. According to the American Veterinary Medical Association (AVMA), Lyme disease is one of the most commonly reported vector-borne diseases in dogs in the United States, with prevalence varying significantly by geographic region.

In Europe, the Federation of Veterinarians of Europe (FVE) recognizes Lyme borreliosis as a significant canine health concern, particularly in central and northern European countries. The European Centre for Disease Prevention and Control (ECDC) monitors tick distribution and Borrelia prevalence across member states. In Australia, the situation is distinct: while Australian veterinarians should be aware of Lyme disease, the Australian Veterinary Association (AVA) notes that locally acquired canine Lyme disease has not been definitively confirmed, though the bacteria have been found in ticks and some animals. The disease is considered endemic in many parts of North America, Europe, and Asia.

2. Pathophysiology: How Borrelia burgdorferi Causes Disease

To fully understand lyme disease symptoms in dogs, one must appreciate the pathophysiological journey of the spirochete. The infection process begins when an infected Ixodes tick attaches to a dog and feeds for 24 to 48 hours. During this feeding period, Borrelia burgdorferi organisms migrate from the tick's midgut to its salivary glands and are transmitted into the dog's bloodstream.

Once in the host, the spirochetes disseminate rapidly. They have a remarkable ability to evade the immune system through antigenic variation, altering their surface proteins (primarily outer surface proteins OspA, OspC, and VlsE) to avoid detection. The bacteria preferentially localize to connective tissues, particularly:

• Joints and periarticular tissues: This explains the hallmark lameness and arthritis.
• Skin and subcutaneous tissues: Localized inflammation may occur at the tick bite site.
• Nervous system: Though less common in dogs than in humans, neurological involvement can occur.
• Kidneys: The most serious complication, Lyme nephritis, involves immune complex deposition in the glomeruli.

The clinical signs of Lyme disease are largely due to the host's inflammatory response to the bacteria, rather than direct tissue destruction by the spirochetes themselves. This immune-mediated component explains why symptoms can wax and wane, and why some dogs develop chronic disease even after the bacteria are cleared.

3. Clinical Presentation: The Spectrum of Lyme Disease Symptoms in Dogs

The clinical signs of Lyme disease in dogs are highly variable. It is estimated that 5% to 10% of infected dogs develop clinical illness, while the remainder remain subclinically infected. The incubation period from tick attachment to clinical signs is typically 2 to 5 months.

3.1 Acute Lyme Disease Symptoms

The classic presentation of acute Lyme disease in dogs includes:

• Shifting-leg lameness (acute arthritis): This is the most characteristic sign. The dog may be lame on one leg for 2 to 4 days, then the lameness shifts to another leg, often with apparent recovery between episodes. The lameness is typically non-weight-bearing or partial weight-bearing.
• Fever: Body temperature often ranges from 39.5°C to 40.5°C (103°F to 105°F). Fever may be intermittent.
• Lethargy and depression: Affected dogs often appear tired, reluctant to exercise, and may sleep more than usual.
• Anorexia: Reduced appetite or complete food refusal is common during acute episodes.
• Lymphadenopathy: Enlarged, sometimes painful lymph nodes (especially the submandibular, prescapular, and popliteal nodes).
• Joint swelling and pain: On physical examination, affected joints (most commonly the carpus, tarsus, and stifle) may be warm, swollen, and painful on palpation and manipulation.
• Stiff gait: Dogs may walk with a stiff, stilted gait, particularly after rest.

3.2 Chronic and Subclinical Lyme Disease

Many dogs remain seropositive (have antibodies against B. burgdorferi) without ever showing clinical signs. These subclinically infected dogs serve as reservoirs for ticks. Chronic Lyme disease in dogs is less clearly defined than in humans, but may manifest as:

• Recurrent or persistent lameness: Episodes of lameness may recur weeks to months apart.
• Chronic polyarthritis: Persistent inflammation in multiple joints, leading to long-term stiffness and discomfort.
• Mild, intermittent lethargy and fever: Owners may notice their dog has "off days" without obvious cause.
• Behavioral changes: Some dogs may become irritable or less tolerant of handling due to joint pain.

3.3 Lyme Nephritis: The Most Serious Complication

Lyme nephritis is a severe, often fatal immune-mediated glomerulonephritis that occurs in a subset of infected dogs. It is more common in Labrador Retrievers, Golden Retrievers, and Shetland Sheepdogs, but any breed can be affected. Signs of lyme disease in dogs involving the kidneys include:

• Polyuria and polydipsia (increased urination and thirst): Often the first signs noticed by owners.
• Vomiting and diarrhoea/diarrhea:
• Weight loss and muscle wasting:
• Peripheral edema (swelling in the limbs, under the jaw, or in the abdomen): Due to protein loss through the kidneys.
• Ascites (fluid accumulation in the abdomen):
• Oral ulcers and uremic breath: In advanced cases.

Lyme nephritis carries a poor prognosis, with mortality rates exceeding 80% despite aggressive treatment.

3.4 Neurological and Cardiac Signs

Neurological involvement is less common in dogs than in humans but can occur. Possible signs include:

• Facial nerve paralysis: Drooping of the ear, lip, or eyelid on one side.
• Seizures: Rarely reported.
• Ataxia and incoordination:
• Hyperesthesia (increased sensitivity to touch):

Cardiac manifestations (Lyme carditis) are extremely rare in dogs but could theoretically cause arrhythmias or heart block.

4. Regional Variations in Lyme Disease Presentation

4.1 North America (USA and Canada)

In the United States, Lyme disease is highly endemic in the Northeast (Maine to Virginia), the Upper Midwest (Wisconsin, Minnesota, Michigan), and to a lesser extent on the West Coast (Northern California, Oregon). The Canadian Veterinary Medical Association (CVMA) notes increasing prevalence in southern Ontario, Quebec, Manitoba, and the Maritime provinces as tick ranges expand due to climate change.

In these regions, the classic shifting-leg lameness is the most common presenting complaint. The Cornell College of Veterinary Medicine emphasizes that Lyme nephritis is a particular concern in endemic areas, and any dog with a positive Lyme test showing proteinuria (protein in the urine) should be evaluated urgently.

4.2 Europe

European Lyme disease is caused primarily by Borrelia afzelii and Borrelia garinii, in addition to B. burgdorferi sensu stricto. The clinical presentation in dogs is similar to North America, but some studies suggest a higher prevalence of subclinical infection. The European Scientific Counsel on Companion Animal Parasites (ESCCAP) provides guidelines for diagnosis and management across Europe.

Dogs in the UK, Ireland, Scandinavia, Germany, France, Switzerland, Austria, and Central Europe are at highest risk. The FVE recommends routine tick control in endemic areas.

4.3 Australia and New Zealand

The status of Lyme disease in Australia is controversial. While Borrelia burgdorferi has been detected in ticks and some native animals, the AVA states that there is no definitive evidence of locally acquired canine Lyme disease causing clinical illness. Most cases diagnosed in Australia are in dogs that have traveled from endemic regions. However, Australian veterinarians should remain vigilant, and the clinical signs described in this guide should prompt consideration of Lyme disease in dogs with appropriate travel history.

New Zealand is currently considered free of Lyme disease, with strict biosecurity measures in place.

5. Diagnostic Approach: Confirming Lyme Disease in Dogs

Diagnosis of Lyme disease is based on a combination of history, clinical signs, and laboratory testing. The Merck Veterinary Manual provides detailed diagnostic algorithms.

5.1 History and Physical Examination

Key historical points include:

• Tick exposure: Known tick infestation, recent travel to endemic areas, or living in a high-risk region.
• Vaccination status: Vaccinated dogs may test positive on serology but are less likely to develop clinical disease.
• Onset and progression of lameness: Acute, shifting-leg lameness is highly suggestive.

Physical examination should include:

• Orthopedic exam: Palpation of all joints for swelling, heat, and pain. Range of motion assessment.
• Neurological exam: Cranial nerve assessment, gait analysis, spinal palpation.
• Lymph node evaluation:
• Temperature measurement:
• Auscultation of heart and lungs:

5.2 Serological Testing

Serology is the mainstay of diagnosis. The most commonly used tests detect antibodies against the C6 peptide of VlsE, a highly specific surface protein of B. burgdorferi.

• In-clinic SNAP tests (e.g., IDEXX SNAP 4Dx Plus): These tests detect antibodies to C6 peptide, as well as antigens for heartworm, Ehrlichia canis, and Anaplasma phagocytophilum. A positive C6 antibody test indicates exposure to B. burgdorferi.
• Quantitative C6 antibody tests: These measure the level of C6 antibody. Higher levels are more strongly associated with active clinical disease. A negative test in a dog with clinical signs does not rule out Lyme disease, as seroconversion can take 4 to 6 weeks.
• Western blot: Used as a confirmatory test in some reference laboratories.

Important caveat: A positive serology test indicates exposure and infection, but does not confirm that current clinical signs are due to Lyme disease. Many healthy dogs in endemic areas are seropositive. Diagnosis of clinical Lyme disease requires a positive test PLUS compatible clinical signs PLUS response to treatment.

5.3 Other Laboratory Findings

• Complete Blood Count (CBC): May be normal or show mild anemia, leukocytosis (increased white blood cells), or thrombocytopenia (low platelets).
• Serum Chemistry: May be normal. In Lyme nephritis, there will be elevated BUN and creatinine (azotemia), hyperphosphatemia, and hypoalbuminemia.
• Urinalysis: Critical for all Lyme-positive dogs. Proteinuria (protein in the urine) is the earliest indicator of Lyme nephritis. A urine protein:creatinine (UPC) ratio should be performed if proteinuria is detected.
• Synovial Fluid Analysis: Arthrocentesis (joint tap) reveals inflammatory, non-septic arthritis with neutrophilic predominance. Borrelia organisms are rarely seen on cytology.

5.4 Advanced Diagnostics

• PCR (Polymerase Chain Reaction): Can detect Borrelia DNA in blood, synovial fluid, or tissue samples. Sensitivity is variable, especially in blood after the acute phase.
• Quantitative PCR (qPCR): More sensitive than standard PCR.
• Renal biopsy: May be indicated in suspected Lyme nephritis to confirm immune complex glomerulonephritis.

6. Differential Diagnoses: Ruling Out Other Conditions

Many conditions mimic lyme disease symptoms in dogs. A thorough diagnostic workup is essential to avoid misdiagnosis. Key differentials include:

7. Treatment Protocols for Canine Lyme Disease

Treatment aims to eliminate the spirochete and manage the inflammatory response. The standard of care, as recommended by the AVMA and AAHA, is outlined below.

7.1 Antibiotic Therapy

• First-line antibiotic: Doxycycline

  • Dose: 10 mg/kg orally every 12 to 24 hours.
  • Duration: 30 days minimum. Some experts recommend 30 to 60 days.
  • Mechanism: Bacteriostatic, inhibits protein synthesis. Highly effective against Borrelia.
  • Side effects: Vomiting, diarrhoea/diarrhea, photosensitivity. In puppies and pregnant dogs, doxycycline can cause tooth discoloration and bone growth abnormalities.

• Alternative antibiotics:

  • Amoxicillin: 20 mg/kg orally every 8 to 12 hours (for puppies and pregnant dogs).
  • Cefovecin (Convenia): A long-acting injectable cephalosporin. Some studies show efficacy, but it is not considered first-line. Dose: 8 mg/kg subcutaneously, repeated in 14 days.
  • Azithromycin: 10 mg/kg orally every 24 hours. Less commonly used.

Important: A rapid clinical response (within 24 to 48 hours) is expected with appropriate antibiotic therapy. Lack of response should prompt reconsideration of the diagnosis.

7.2 Supportive and Anti-inflammatory Therapy

• Non-steroidal anti-inflammatory drugs (NSAIDs): For pain and fever. Examples: carprofen (2.2 mg/kg twice daily), meloxicam (0.1 mg/kg once daily), firocoxib (5 mg/kg once daily). Use with caution in dogs with kidney disease.
• Corticosteroids: Generally avoided in acute Lyme disease as they can suppress the immune response. However, in severe immune-mediated polyarthritis or Lyme nephritis, short-term immunosuppressive doses of prednisone (1 to 2 mg/kg/day) may be necessary.
• Fluid therapy: For dehydrated or febrile dogs.
• Rest: Strict rest for 2 to 4 weeks to allow joint inflammation to subside.

7.3 Treatment of Lyme Nephritis

Lyme nephritis requires aggressive, multi-modal therapy and carries a guarded prognosis.

• Hospitalization and intravenous fluids: To manage azotemia and maintain hydration.
• Antibiotics: Doxycycline as above.
• Immunosuppression: Prednisone (1 to 2 mg/kg/day) or other immunosuppressants (e.g., mycophenolate mofetil, cyclophosphamide).
• ACE inhibitors: Enalapril or benazepril (0.5 mg/kg once daily) to reduce proteinuria and glomerular hypertension.
• Antiplatelet therapy: Low-dose aspirin or clopidogrel to reduce thrombotic risk.
• Dietary management: Low-protein, low-phosphorus, omega-3 fatty acid enriched renal diet.
• Dialysis: May be considered in severe cases at specialized centers, but is rarely performed.

8. Prevention Strategies

Prevention is far more effective than treatment. The AVMA, CVMA, and FVE all emphasize a multi-modal approach to tick-borne disease prevention.

8.1 Tick Control Products

• Topical spot-ons: Fipronil, permethrin (dogs only, toxic to cats), imidacloprid, selamectin.
• Oral chews: Isoxazolines (afoxolaner, fluralaner, sarolaner, lotilaner). These are highly effective and convenient. They kill ticks within hours of attachment, reducing transmission risk.
• Collars: Flumethrin/imidacloprid collars (e.g., Seresto) provide long-lasting protection.
• Sprays and powders: Less commonly used.

Application frequency: Most products are monthly; some oral isoxazolines last 12 weeks. Follow manufacturer instructions.

8.2 Vaccination

The Lyme vaccine for dogs is a bacterin-based vaccine that targets B. burgdorferi. It is considered a non-core vaccine by the AAHA and WSAVA (World Small Animal Veterinary Association) guidelines.

• Indications: Dogs living in or traveling to highly endemic areas with significant tick exposure.
• Efficacy: Reduces the risk of clinical disease but does not prevent infection entirely. Vaccinated dogs may still become infected and seropositive.
• Schedule: Initial two-dose series 2 to 4 weeks apart, then annual boosters.
• Side effects: Mild local reactions, lethargy, fever. Vaccine-associated immune-mediated disease is a rare but reported complication.

Important: Vaccination does not replace the need for tick control. A multi-modal approach (vaccine + tick prevention) provides the best protection.

8.3 Environmental and Behavioral Measures

• Tick checks: Inspect dogs daily after walks in wooded or grassy areas. Pay attention to the head, neck, ears, axillae, and groin.
• Tick removal: Use fine-tipped tweezers or a tick removal tool. Grasp the tick as close to the skin as possible and pull straight out with steady, even pressure. Do not twist or crush the tick.
• Landscaping: Keep grass short, remove leaf litter, and create barriers between wooded areas and lawns.
• Avoidance: Walk on cleared paths, avoid tall grass and brush during peak tick season (spring, summer, fall).

9. Prognosis and Long-term Outlook

The prognosis for dogs with acute Lyme disease is excellent with appropriate antibiotic therapy. Most dogs show significant improvement within 24 to 48 hours of starting treatment, and the majority recover fully.

• Relapse: Some dogs may experience recurrence of lameness weeks to months later, requiring retreatment.
• Chronic infection: Even after treatment, Borrelia DNA can sometimes be detected in tissues, suggesting that complete eradication may not always occur. However, clinical disease is usually controlled.
• Lyme nephritis: The prognosis is poor to grave. Despite aggressive therapy, many dogs progress to end-stage renal failure and die or are euthanized within weeks to months of diagnosis. Early detection of proteinuria is critical.
• Neurological Lyme: Prognosis is guarded but some dogs recover with prolonged antibiotic therapy.

10. Special Considerations

10.1 Co-infections

Ticks often carry multiple pathogens simultaneously. Dogs with Lyme disease may also be infected with Anaplasma phagocytophilum, Ehrlichia canis, Babesia species, or Bartonella species. Co-infections can complicate the clinical picture and may require additional or modified treatment.

10.2 Lyme Disease in Cats

While cats can be infected with Borrelia burgdorferi, clinical Lyme disease in cats is extremely rare. The Cornell Feline Health Center notes that most infected cats remain asymptomatic. When symptoms do occur, they may include fever, lethargy, lameness, and anorexia. Diagnosis and treatment are similar to dogs, but feline-specific antibiotic doses and safety considerations apply.

10.3 Zoonotic Risk

Lyme disease is a zoonotic disease, meaning it can be transmitted from animals to humans. However, dogs do not directly transmit Lyme disease to humans. Humans contract Lyme disease from the same infected Ixodes ticks that bite dogs. Therefore, a dog with Lyme disease in the household indicates that infected ticks are present in the environment, and all family members should take tick precautions.

11. Frequently Asked Questions (FAQs)

Q: Can my dog die from Lyme disease? A: Yes, but it is rare. The most common cause of death is Lyme nephritis, a severe kidney complication. With prompt treatment of acute Lyme disease, the prognosis is excellent.

Q: How long does it take for a dog to show signs of Lyme disease after a tick bite? A: The incubation period is typically 2 to 5 months. Not all tick bites result in infection, and not all infected dogs develop clinical signs.

Q: Can a dog get Lyme disease more than once? A: Yes. Infection does not confer lifelong immunity. Dogs can be re-infected if exposed to infected ticks again.

Q: Is there a test for Lyme disease in dogs? A: Yes. The most common test is the in-clinic SNAP test that detects antibodies to the C6 peptide. This test is often combined with tests for other tick-borne diseases.

Q: Should I vaccinate my dog against Lyme disease? A: Discuss with your veterinarian. Vaccination is recommended for dogs at high risk of tick exposure in endemic areas. It is not a substitute for tick control.

Q: What should I do if I find a tick on my dog? A: Remove it promptly with tweezers, grasping as close to the skin as possible and pulling straight out. Clean the area with antiseptic. Monitor your dog for signs of lameness, fever, or lethargy over the next 2 to 5 months.

12. Regional Guidelines and Resources

• USA: AVMA Lyme Disease Brochure, AAHA Canine Vaccination Guidelines, CDC Tickborne Diseases.
• Canada: CVMA Position Statement on Lyme Disease, Public Health Agency of Canada Lyme Disease Surveillance.
• Europe: FVE Vector-Borne Diseases Guidelines, ESCCAP Control of Ectoparasites in Dogs and Cats.
• Australia: AVA Tick Paralysis and Lyme Disease Fact Sheet, DAFF Biosecurity Import Conditions.
• UK: British Small Animal Veterinary Association (BSAVA) Guide to Tick-Borne Diseases.

13. Conclusion

Lyme disease remains a significant and growing concern in canine medicine across the Northern Hemisphere. The hallmark lyme disease symptoms in dogs include acute, shifting-leg lameness, fever, lethargy, and lymphadenopathy. However, the clinical spectrum is broad, ranging from asymptomatic infection to life-threatening Lyme nephritis.

Veterinary professionals must maintain a high index of suspicion in endemic areas, utilize appropriate diagnostic tests (serology, urinalysis, and synovial fluid analysis), and initiate prompt antibiotic therapy with doxycycline. Prevention through rigorous tick control and, where indicated, vaccination is paramount.

By understanding the full range of signs of lyme disease in dogs, practitioners can ensure timely diagnosis, effective treatment, and improved outcomes for their canine patients. As tick ranges continue to expand due to climate change and habitat alteration, Lyme disease will remain a critical topic in companion animal medicine for years to come.

References

1. Littman MP, Gerber B, Goldstein RE, et al. ACVIM consensus update on Lyme borreliosis in dogs and cats. J Vet Intern Med. 2018;32(3):887-903.
2. Krupka I, Straubinger RK. Lyme borreliosis in dogs and cats: background, diagnosis, treatment and prevention. Vet Clin North Am Small Anim Pract. 2010;40(6):1103-1119.
3. American Veterinary Medical Association (AVMA). Lyme Disease in Dogs. Available at: https://www.avma.org/resources-tools/pet-owners/petcare/lyme-disease-dogs.
4. Canadian Veterinary Medical Association (CVMA). Lyme Disease in Dogs. Available at: https://www.canadianveterinarians.net/.
5. Federation of Veterinarians of Europe (FVE). Vector-Borne Diseases in Dogs and Cats. Position Paper.
6. European Scientific Counsel on Companion Animal Parasites (ESCCAP). Control of Ectoparasites in Dogs and Cats. Guideline 3.
7. Merck Veterinary Manual. Lyme Borreliosis in Dogs. Available at: https://www.merckvetmanual.com/.
8. Cornell Feline Health Center. Lyme Disease in Cats. Available at: https://www.vet.cornell.edu/.
9. Australian Veterinary Association (AVA). Lyme Disease in Australia. Fact Sheet.
10. VCA Animal Hospitals. Lyme Disease in Dogs. Available at: https://vcahospitals.com/.
11. DVM360. Canine Lyme Disease: Diagnosis, Treatment, and Prevention. Available at: https://www.dvm360.com/.
12. AAHA/AVMA. Canine Vaccination Guidelines. 2022.
13. Centers for Disease Control and Prevention (CDC). Tickborne Diseases of the United States. Available at: https://www.cdc.gov/ticks/.
14. Public Health Agency of Canada. Lyme Disease Surveillance. Available at: https://www.canada.ca/.
15. European Centre for Disease Prevention and Control (ECDC). Tick-borne diseases. Available at: https://www.ecdc.europa.eu/.